[对胺反应性巨型血性贫血综合征的图书统计可视化分析]
1Department of Clinical Laboratory, the First Affiliated Hospital of Guangxi Medical University,Key Laboratory of Clinical Laboratory Medicine of Guangxi Department of Education, Nanning 530021,China.
概括
这项研究分析了从1997年到2023年间的胺反应性巨细胞贫血综合征 (TRMA) 研究. 关键发现突出了溶解物载体家族19成员2 (SLC19A2) 基因作为理解TRMA机制的潜在突破.
科学领域:
- 遗传学和分子生物学
- 内分泌学 在内分泌学.
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
背景情况:
- 胺响应性巨细胞贫血综合征 (TRMA) 是一种罕见的遗传疾病.
- 了解TRMA的致病机制和预防策略至关重要.
研究的目的:
- 通过视觉分析TRMA研究的现状,趋势和前景.
- 确定TRMA当前的研究热点和未来的方向.
- 为TRMA的致病机制和预防提供见解.
主要方法:
- 从1997年到2023年,对TRMA相关文献进行了图书统计分析.
- 利用了Web of Science数据库和R软件进行数据分析.
- 关键词频率分析以确定研究趋势.
主要成果:
- 在1997年至2023年期间,确定了89篇关于TRMA的出版物.
- 美国和以色列是TRMA研究的主要贡献者.
- 常见的关键词包括糖尿病,聋,TRMA和SLC19A2基因突变.
结论:
- TRMA的研究集中在与糖尿病,聋和综合征本身相关的机制上.
- 溶解物载体家族19成员2 (SLC19A2) 基因为TRMA的未来分子研究提供了一个有希望的领域.
相关概念视频
Disorders of Erythrocytes
2.7K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.7K
Vitamins
2.7K
Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
2.7K
Inborn Errors of Metabolism
1.1K
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.1K
Measurement of Bioavailability: Pharmacodynamic Methods
1.0K
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
1.0K
Therapeutic Drug Monitoring: Affecting Factors
429
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
429
Therapeutic Drug Monitoring: Drug Analysis Methods
342
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
342


